Eflornithine cream

• Before you start the treatment, read the manufacturer's printed information leaflet from inside the pack. It will give you more information about eflornithine cream and will provide you with a full list of the side-effects which you may experience from using it.
• If you have just used a hair remover or shaved, leave at least five minutes before you apply eflornithine cream. This will help to reduce any stinging or burning, which could otherwise occur.
• Apply eflornithine cream twice a day to the areas of your face or chin which are affected. You should leave at least eight hours between the two applications. You only need to apply a thin layer of cream and you should rub it in well (until you can no longer see any cream on your face). Try not to get any cream in or near your eyes or mouth, as it may cause irritation.
• After applying the cream, you should wash your hands to remove any cream left on your fingers but, if possible, do not wash your face during the following four hours.

• Eflornithine cream is not a depilatory cream. You may need to continue with your usual hair removal routines. Ways to remove unwanted hair include shaving, plucking, waxing, hair-removing creams, electrolysis, and laser treatments. Your doctor wil advise you about which of these are suitable for you to use alongside eflornithine cream.
• If you want to apply make-up to the areas of skin that you've applied the cream to, you can do this, but please wait for at least five minutes after applying eflornithine cream before you do so.
• It is important that you use the cream regularly. It can take about eight weeks before you start to see the full benefit from using it. If after four months of using the cream there is little improvement, please discuss this with your doctor who will review your treatment.
• Eflornithine cream must not be used by men, or girls under 18 years old.

• Keep all medicines out of the reach and sight of children.
• Store in a cool, dry place, away from direct heat and light.

Pregnancy Category: C

Lactation: Not known whether distributed into breast milk; use caution

Pregnancy Categories

A:Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk.

B:May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk.

C:Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done.

D:Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk.

X:Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist.

NA:Information not available.